There is currently a lack of research on the mechanism of probiotics in the treatment of kidney disease, but a few studies have reported that probiotics, especially Bifidobacterium, could blunt the activating signal of NLRP3 in intestinal tissue. Here, NLRP3 is linked to kidney disorder.